Consolidated Statements of Stockholders' Equity $ in Thousands		USD ($) shares	CAD / shares	Common Shares USD ($) shares	Additional Paid-In Capital USD ($)	Accumulated Deficit USD ($)	Accumulated Other Comprehensive Income USD ($)
Beginning Balance (in shares) at Dec. 31, 2013 | shares	[1]			10,215,985
Beginning Balance at Dec. 31, 2013		$ 157,784		$ 466,229	$ 95,844	$ (507,258)	$ 102,969
Exercise of stock options, for cash (in shares) | shares	[1]			20,809
Exercise of stock options, for cash		509		$ 750	(241)
Shares issued in connection with RSUs vested (in shares) | shares	[1]			2,800
Shares issued in connection with RSUs vested (Note 12)		0		$ 55	(55)
Uncertain tax position liability recovery (Note 13)		837			837
Stock-based compensation expense (Note 12)		1,453			1,453
Foreign currency translation adjustment		0
Net loss		(4,071)				(4,071)
Ending Balance (in shares) at Dec. 31, 2014 | shares	[1]			10,239,594
Ending Balance at Dec. 31, 2014		156,512		$ 467,034	97,838	(511,329)	102,969
Exercise of stock options, for cash, lower range limit price (in cad per share) | CAD / shares			CAD 22.7
Exercise of stock options, for cash, upper range limit price (in cad per share) | CAD / shares			26.9
Exercise of stock options, for cash (in shares) | shares	[1]			313,095
Exercise of stock options, for cash		5,508		$ 8,077	(2,569)
Shares issued in connection with RSUs vested (in shares) | shares	[1]			12,800
Shares issued in connection with RSUs vested (Note 12)		0		$ 222	(222)
Stock-based compensation expense (Note 12)		2,330			2,330
Foreign currency translation adjustment		0
Net loss		(23,009)				(23,009)
Ending Balance (in shares) at Dec. 31, 2015 | shares	[1]			10,565,489
Ending Balance at Dec. 31, 2015		$ 141,341		$ 475,333	97,377	(534,338)	102,969
Exercise of stock options, for cash, lower range limit price (in cad per share) | CAD / shares			20.4
Exercise of stock options, for cash, upper range limit price (in cad per share) | CAD / shares			CAD 22.7
Exercise of stock options, for cash (in shares) | shares		0
Uncertain tax position liability recovery (Note 13)		$ 335			335
Stock-based compensation expense (Note 12)		797			797
Shares issued in connection with the Acquisition of Aegerion (Note 5) (in shares) | shares	[1]			6,060,288
Shares issued in connection with the Acquisition of Aegerion (Note 5)		59,381		$ 59,381
Shares issued in a private placement net of share issuance cost (Note 11) (in shares) | shares	[1]			1,904,546
Shares issued in a private placement net of share issuance cost (Note 11)		21,481		$ 16,545	4,936
Cash distribution to shareholders (Note 4)		(15,000)			(15,000)
Aralez shares distributed to shareholders (Note 4)		(19,296)			(19,296)
Foreign currency translation adjustment		(382)					(382)
Net loss		(52,870)				(52,870)
Ending Balance (in shares) at Dec. 31, 2016 | shares	[1]			18,530,323
Ending Balance at Dec. 31, 2016		$ 135,787		$ 551,259	$ 69,149	$ (587,208)	$ 102,587

[1] Amounts have been retroactively restated for all prior periods presented to reflect the one-for-five share consolidation of the Company’s common stock effected on December 16, 2016.